BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191008
DTEND;VALUE=DATE:20191011
DTSTAMP:20260515T032709
CREATED:20190703T092011Z
LAST-MODIFIED:20190703T092011Z
UID:21420-1570492800-1570751999@www.pharmajournalist.com
SUMMARY:19th Pharmacovigilance 2019
DESCRIPTION:19th Pharmacovigilance 2019 \n“Ensuring safer drugs to market by analyzing latest developments in pharmacovigilance\, drug safety and risk management” \n08th – 10th October 2019\, Hotel TBC\, Cambridge\, Boston\, USA \n19th Pharmacovigilance 2019 will bring together top pharmaceutical\, biotechnology and regulatory representatives under one roof that will address the key issues of the industry.  The entire program will cover the detection\, analysis and prevention of adverse drug reactions.  It will be studied with the help of case studies and industry experiences.  Hence\, this conference will provide an important platform for pharmacovigilance stakeholders to discuss and share best practices in expediting Pv development. \nSPONSORS: \n\nGOLD SPONSOR: Brookwood\, AB Cube\, AWINSA Life Sciences \nBRONZE SPONSOR: 4C Pharma Solutions\n\nKEY SPEAKERS: \n\nDEREK ROY\, Resident Agent in Charge\, FDA\nBRUNO MENDEZ\, VP Global Quality Head Pharmacovigilance\, Sanofi\nMARIETTE BOERSTOEL-STREEFLAND\,  VP PharmacoVigilance & Drug Safety\, Alexion Pharmaceuticals\nTEGINDER SINGH\, Senior Director Global Regulatory Affairs\, Johnson & Johnson\nCOLLEEN WALSH\, Senior Director\, Pharmacovigilance & Regulatory Quality Management Operations\, Alexion Pharmaceuticals\nGERSON PELTZ\, Senior Director – Oncology Safety Risk Lead\, Pfizer\nBRUCE DONZANTI\, Senior Group Director\, Regulatory Pharmacovigilance Policy\, Genentech\nWILLIAM WANG\, Executive Director\, Clinical Safety Statistics\, Merck\nMELVIN MUNSAKA\, Senior Director\, Head Safety Statistics\, Abbvie\nXIAO NI\, Director\, Scientific Computing and Consulting\, Novartis\nSHARON REID\, Director\, Risk Management Product Lead\, Pfizer\nHARISHA KADALI\, Associate Medical Director\, Takeda Pharmaceuticals\nJAYLAXMI NALAWADE\, Associate Director – Pharmacovigilance and REMS\, Lupin\nRICHARD WOLF\, Executive Director\, Pv Operations\, CSL Behring\nPHIL TREGUNNO\, Group Manager – Vigilance\, Intelligence and Research Group\, MHRA (UK)\nTOYIN ADEWOLE\, Associate Director\, Drug Safety – Clinical Research\, Supernus Pharmaceuticals\nSHEETAL KHEDAR\, Senior Director\, Regulatory Science\, Sarah Cannon Development Innovations\nDAVID HUTCHINSON\, Founder\, Brookwood International Academy\nMELVA COVINGTON\, Senior Principal\, AGAPE Strategic Solutions\nBEN LOCWIN\, Senior Vice President\, Quality\, Lumicell\n\nWHO SHOULD ATTEND: \nCEO’s\, CTO’s\, CIO’s\, Presidents\, VPs\, Directors\, Heads\, Managers\, Scientific Advisors\, Consultants of: \nPharmacovigilance\, Pharmacoepidemiology\, Pharmacogenomics\, Drug/Product Safety\, Drug Development\, Information and Clinical Data Management\, Clinical Pharmacology\, Clinical Safety\, Periodical safety update Reports\, Risk Management\, Research & Development\, Quality Assurance\, Patient Safety\, Signal Detection\, Safety Surveillance\, Outcomes Research\, Data Analysis\, Epidemiology\, Medical Affairs\, Regulatory Affairs and Compliance\, Information technology\, Sales and Marketing \nCONFERENCE SPONSORSHIP: \n E-mail – kavitha@virtueinsight.co.in  or Tel: +44 2036120886 \n Sponsor\, Exhibition Stall (Booth) and a paid Speaker Slots are also available. \nWe also have some sponsorship opportunities available for the event\, which gives you an opportunity to sponsor/speak/exhibit\, and create brand awareness. In addition\, the networking opportunities in focused and relevant industry gathering provide the personal contact necessary for business development efforts. \nCONFERENCE REGISTERATION: \nIn order to register contact us on Email: kavitha@virtueinsight.co.in  Tel: +44 2036120886 \nConference Only: \n\nIntroductory Offer (3 delegate places for the price of 2) A huge saving (Limited seats left)\nEarly Discount (25th June 2019 – 19th August 2019): (£1299 per delegate)\nStandard Registration (20th August 2019 Onwards): (£1499 per delegate)\n\nConference + Workshop: \n\nIntroductory Offer (3 delegate places for the price of 2) A huge saving – (Limited seats left)\nEarly Discount (25th June 2019 – 19th August 201): (£1499 per delegate)\nStandard Registration (20th August 2019 Onwards): (£1699 per delegate)\n\nWorkshop Oniy – £399 \nWhether you are on the branded or generic side\, you cannot afford to miss this opportunity to benchmark your tactics and strategies against the industry leaders who will be the first to traverse the pathway.  Devise an immediate action plan for your biosimilar prosecution and litigation strategies in light of the barriers to entry\, research and development costs\, and regulatory hurdles\, which are balanced against an enormous potential for increased profit margins. Expand your knowledge of the latest business models and strategies in the high-level conference.
URL:https://www.pharmajournalist.com/event/19th-pharmacovigilance-2019/
LOCATION:Double Tree Suites by Hilton Hotel – 400 Soldiers Field Road\, Boston\, MA 02134
ORGANIZER;CN="Virtue Insight":MAILTO:kavitha@virtueinsight.co.in
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191008
DTEND;VALUE=DATE:20191010
DTSTAMP:20260515T032709
CREATED:20190729T102418Z
LAST-MODIFIED:20190729T115346Z
UID:21733-1570492800-1570665599@www.pharmajournalist.com
SUMMARY:Blockchain for Health Supply Chain
DESCRIPTION:Blockchain for Health Supply Chain: Real-World Application is the definitive event for all key stakeholders across the supply chain to forge a path for collaboration and adoption of this transformative technology. Consortium and tech-agnostic\, this conference provides a neutral platform for cross-community sharing of PoCs and discussion about the common challenges facing all blockchain implementation projects. \n \nIn its 2nd year\, this event will continue to tackle the deep and difficult challenges associated with blockchain implementation – providing essential guidance for active adopters as well as those preparing to embark on their blockchain journey. Our mission is to help you get beyond PoC – and to get blockchain out of the lab and into business. \nFind out more – get free event brochure here:  https://ter.li/p0t4xu \nContact\n(+1) 617 455 4188\ninfo@hansonwade.com
URL:https://www.pharmajournalist.com/event/blockchain-for-health-supply-chain/
LOCATION:The Westin Boston Waterfront\, 425 Summer St\, Boston\, MA\, 02210\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191009
DTEND;VALUE=DATE:20191011
DTSTAMP:20260515T032709
CREATED:20190513T090618Z
LAST-MODIFIED:20190513T090618Z
UID:20692-1570579200-1570751999@www.pharmajournalist.com
SUMMARY:4th European Prefilled Syringes Summit
DESCRIPTION:After the three successful ACI’s European Prefilled Syringes Summit\, we are pleased to inform you that the 4th edition will take place this month on the 9th & 10th October in Berlin\, Germany. \n \nThe two day event will explore the advancements in regulatory guidelines including Article 117 and what this will mean for interactions with notified bodies. The conference will highlight technical advancements in product design and usage\, looking at the move towards autoinjectors. Our expert speakers will compare the use of glass syringes with plastic syringes\, focus on how to minimise the impact of extractables and leachables\, and address CCI regulations. Through in-depth presentations and interactive panel discussions\, the conference will shed light onto how the industry is responding to disruptive technology\, connectivity\, speed to market\, and next generation syringes. \nKey Topics Include: \n\nMedical Device Regulations overview and updates\nTechnical advancements in product design and usage\nSuitability of primary packaging components\nExtractables and leachables\nManufacturing and supply barriers\nImproving adherence through device innovation and human factors\nCreating value with connectivity\nDevelopments in biologics\nShifting to a pay-per-outcome market\n\nFor more information & 15% subscribers discounted registration\, contact Mohammad Ahsan on +44 (0) 203 141 0606 or email: mahsan@acieu.net   \nJoin us in Berlin to exchange your point of view with your peers and engage in excellent networking opportunities.
URL:https://www.pharmajournalist.com/event/4th-european-prefilled-syringes-summit/
LOCATION:Berlin\, Germany
ORGANIZER;CN="Active Communications Europe Ltd (ACI)":MAILTO:mahsan@acieu.net
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191009
DTEND;VALUE=DATE:20191011
DTSTAMP:20260515T032709
CREATED:20190517T135859Z
LAST-MODIFIED:20190814T090558Z
UID:20796-1570579200-1570751999@www.pharmajournalist.com
SUMMARY:Pharmaceutical Cleanroom Technology Europe Conference
DESCRIPTION:SMi’s Pharmaceutical Cleanroom Technology Europe Conference\nConference: Wednesday 9 and Thursday 10 October 2019\nWorkshop: Tuesday 8 October 2019\nLocation: Copthorne Tara Hotel\, London\, UK\nwww.cleanroomtechnology.co.uk/pjwl  \nSponsored by: Contec and Dupont  \nCHAIRMAN: James Drinkwater\, Chairman\, Pharmaceutical & Healthcare Science Society  \nAddressing the Microbiological Aspects in Cleanroom Design and Engineering \nSMi Group are pleased to announce the Inaugural Pharmaceutical Cleanroom Technology Europe Conference\, taking place on the 9th and 10th October 2019 in London\, UK. As the first event in Europe that focuses on cleanroom technology in the pharmaceutical industry\, the conference will serve to bridge that gap between the two areas while simultaneously providing a unique selling point. \n \nThis one-of-a-kind meeting will facilitate networking opportunities with key opinion leaders from all areas of pharmaceuticals\, biologicals\, and cleanroom industry experts to explore hot topics within cleanroom design and engineering\, best practices and regulation\, environmental and contamination control\, and pharmaceutical microbiology. \nIn 2025\, the global cleanroom technology market is expected to reach nearly $5 billion. Stringent regulatory standards for product approvals\, technological advancements in cleanrooms\, initiatives taken by private organisations to create awareness regarding cleanroom and growth of the healthcare sector globally are among the few factors expected to drive the market. \nCompliance with the standards for product approvals is crucial and as a result manufacturing companies in various industries are dependent on cleanroom technology.  \nBENEFITS OF ATTENDING \n\nEXPLORE the characteristics and relevance of air flow to better advise cleanroom design\, engineering and manage contamination\nDISCUSS the most current approaches to minimised cost and improved energy efficiency without compromising product quality\nEXAMINE the latest contamination control strategies from leaders in the pharmaceutical industry\nGAIN insight into cleaning and disinfection protocols from a risk-management approach\n\n PLUS AN INTERACTIVE HALF DAY PRE-CONFERENCE WORKSHOP \nTuesday 8th October 2019\, Copthorne Tara Hotel\, London\, UK \nEnvironmental Classification\, Qualification and Monitoring of GMP Controlled areas referencing ISO 14644-1 and risk based GMP \nWorkshop Leader: James Drinkwater\, Chairman\, Pharmaceutical and Healthcare Science Society \nWHO SHOULD ATTEND? \nSenior Micro Manager\, QC Manager\, Quality Director\, Clean Room Design Managers\, Design\, Qualify and Testing – Clean Room (across the board)\, Head of Clean Room Technologies\, Head of Compounding Pharmacies\, Head of Clinical Drug Products\, Head of Clinical Medical Device \nGlobal Presence: Attendees from all over the world attend our events. Gain hands on insight from representatives from UK\, Europe and USA. \nEARLY BIRD-RATES \n\nBOOK BY 31ST MAY AND SAVE £400\nBOOK BY 28TH JUNE AND SAVE £300\nBOOK BY 30th AUGUST AND SAVE £200
URL:https://www.pharmajournalist.com/event/pharmaceutical-cleanroom-technology-europe/
LOCATION:Copthorne Tara Hotel\, Scarsdale Place\, Kensington\, London\, W8 5SY\, United Kingdom
ORGANIZER;CN="SMi Group":MAILTO:ssapal@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191010
DTEND;VALUE=DATE:20191012
DTSTAMP:20260515T032709
CREATED:20190124T074007Z
LAST-MODIFIED:20190124T074007Z
UID:19196-1570665600-1570838399@www.pharmajournalist.com
SUMMARY:Novel Antibody Therapeutics Congress
DESCRIPTION:The Novel Antibody Therapeutics Congress one of five co-located conferences exploring key areas in immuno-oncology. The Research & Technology Series will attract over 100 speakers and 350+ attendees. These interactive meetings provide the opportunity to keep up to date with the cutting edge of research and make connections with industry experts\, researchers\, investors and businesses.
URL:https://www.pharmajournalist.com/event/novel-antibody-therapeutics-congress/
LOCATION:London\, United Kingdom – Venue to be confirmed
ORGANIZER;CN="Global Engage":MAILTO:info@globalengage.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191010
DTEND;VALUE=DATE:20191012
DTSTAMP:20260515T032709
CREATED:20190124T074341Z
LAST-MODIFIED:20190124T074341Z
UID:19201-1570665600-1570838399@www.pharmajournalist.com
SUMMARY:Adoptive Cell Transfer Congress
DESCRIPTION:The Adoptive Cell Transfer Congress is one of five co-located conferences exploring key areas in immuno-oncology. The Research & Technology Series will attract over 100 speakers and 350+ attendees. These interactive meetings provide the opportunity to keep up to date with the cutting edge of research and make connections with industry experts\, researchers\, investors and businesses.
URL:https://www.pharmajournalist.com/event/adoptive-cell-transfer-congress/
LOCATION:London\, United Kingdom – Venue to be confirmed
ORGANIZER;CN="Global Engage":MAILTO:info@globalengage.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191010
DTEND;VALUE=DATE:20191012
DTSTAMP:20260515T032709
CREATED:20190124T074554Z
LAST-MODIFIED:20190124T074554Z
UID:19206-1570665600-1570838399@www.pharmajournalist.com
SUMMARY:TMB & Neoantigen Congress
DESCRIPTION:The TMB & Neoantigen Congress is one of five co-located conferences exploring key areas in immuno-oncology. The Research & Technology Series will attract over 100 speakers and 350+ attendees. These interactive meetings provide the opportunity to keep up to date with the cutting edge of research and make connections with industry experts\, researchers\, investors and businesses.
URL:https://www.pharmajournalist.com/event/tmb-neoantigen-congress/
LOCATION:London\, United Kingdom – Venue to be confirmed
ORGANIZER;CN="Global Engage":MAILTO:info@globalengage.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191010
DTEND;VALUE=DATE:20191012
DTSTAMP:20260515T032709
CREATED:20190124T074802Z
LAST-MODIFIED:20190124T074802Z
UID:19211-1570665600-1570838399@www.pharmajournalist.com
SUMMARY:Liquid Biopsies Congress
DESCRIPTION:The Liquid Biopsies Congress is one of five co-located conferences exploring key areas in immuno-oncology. The Research & Technology Series will attract over 100 speakers and 350+ attendees. These interactive meetings provide the opportunity to keep up to date with the cutting edge of research and make connections with industry experts\, researchers\, investors and businesses.
URL:https://www.pharmajournalist.com/event/liquid-biopsies-congress/
LOCATION:London\, United Kingdom – Venue to be confirmed
ORGANIZER;CN="Global Engage":MAILTO:info@globalengage.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191010
DTEND;VALUE=DATE:20191012
DTSTAMP:20260515T032709
CREATED:20190124T075036Z
LAST-MODIFIED:20190124T075036Z
UID:19216-1570665600-1570838399@www.pharmajournalist.com
SUMMARY:Flow Cytometry Congress
DESCRIPTION:The Flow Cytometry is one of five co-located conferences exploring key areas in immuno-oncology. The Research & Technology Series will attract over 100 speakers and 350+ attendees. These interactive meetings provide the opportunity to keep up to date with the cutting edge of research and make connections with industry experts\, researchers\, investors and businesses.
URL:https://www.pharmajournalist.com/event/flow-cytometry-congress/
LOCATION:London\, United Kingdom – Venue to be confirmed
ORGANIZER;CN="Global Engage":MAILTO:info@globalengage.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191015
DTEND;VALUE=DATE:20191017
DTSTAMP:20260515T032709
CREATED:20190509T101547Z
LAST-MODIFIED:20190509T110535Z
UID:20621-1571097600-1571270399@www.pharmajournalist.com
SUMMARY:SMi’s 9th Annual Orphan Drugs & Rare Diseases Conference
DESCRIPTION:SMi Group are proud to announce the 9th Annual Orphan Drugs and Rare Diseases Conference\, taking place on the 15th and 16th October 2019 in London\, UK. \n \nThe orphan drug market is continuously growing and is expected to reach $176 billion by 2020\, with a CGR of 10.5% just for orphan drugs – this is twice the growth rate of the overall prescription drug market (5.3% CGR from 2014-2020). By 2020\, orphan drugs are set to account for 19% of global prescription sales. \nThis is due to the arising interest for pharmaceutical companies\, primarily for the underlying benefits\, including the potential discovery of mechanisms for more common diseases\, and the involvement of many smaller biotechnology start-up companies who are more focused on rare diseases. \nThe 2019 agenda features various key presentations by leading solution providers\, biotechnology companies\, clinical researchers\, regulatory professionals and charity leaders discussing possible ways to accelerative orphan drug development and access to rare disease patients\, including the introduction of recent technologies and products to help aid the access of orphan drugs. \nBENEFITS OF ATTENDING \n\nHEAR about the success of orphan drug launches following the heavy involvement of patient advocacy programs\nDISCUSS the potential changes in assessing the development of medicines across Europe\nEXPLORE the future landscape orphan drugs following the market access and reimbursement challenges providers are currently facing.\n\nPLUS AN INTERACTIVE HALF-DAY POST-CONFERENCE WORKSHOP\nThursday 17th October 2019\nA deep dive into strategies for accelerating patient access of orphan drugs\nWorkshop Leader: Workshop Leaders: Solange Corriol-Rohou\, Senior Director Regulatory Affairs & Policy Europe\, AstraZeneca\nCecile Ollivier\, Chief Operating Officer\, Aparito \nWHO SHOULD ATTEND? \nCEOs\, CSOs\, Vice Presidents\, Directors\, Heads\, Principals working in: \n\nMedical Affairs\nMedical Advisory\nClinical Operations\nRare Disease Research\nPatient Advocacy\nCommercial Officer\nOrphan Drug Therapeutics\nHealthcare\nRegulatory Affairs\nRare Disease Charity Officers\n\nFor more details and to register or this event\, visit the website at http://www.orphandrugs.co.uk/PJWL \nEARLY BIRD-RATES  \n\nBOOK BY 31ST MAY AND SAVE £400\nBOOK BY 28TH JUNE AND SAVE £300\nBOOK BY 30TH AUGUST AND SAVE £200
URL:https://www.pharmajournalist.com/event/orphan-drugs-rare-diseases-conference/
LOCATION:Holiday Inn Kesington Forum\, London\, UK\, London\, United Kingdom
ORGANIZER;CN="SMi Group Ltd":MAILTO:ssapal@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191015
DTEND;VALUE=DATE:20191017
DTSTAMP:20260515T032709
CREATED:20190625T112416Z
LAST-MODIFIED:20190625T112709Z
UID:21320-1571097600-1571270399@www.pharmajournalist.com
SUMMARY:Marketing and Customer Innovation Europe
DESCRIPTION:We’re at a crossroads. On the one hand\, pharma marketeers must adopt and master an array of technological innovations to transform customer relationships and better meet rising expectations. \nOn the other\, successful innovation is currently inhibited by our failure to master the basics – with inconsistent multichannel interaction and a low cultural acceptance of non-traditional methods\, whether it’s digital or education-led initiatives. \nLet’s build the capability to create new collaborations and partnerships\, both internally and externally\, to strengthen what’s possible yet at the same time deliver on the fundamentals of customer-value. It’s no longer a nice-to-have – we must do this or face rapid extinction.  \neyeforpharma Marketing and Customer Innovation Europe will bring together 250+ Marketing\, Digital\, CX\, IT/CRM and Business Partnership/Technology pharma executives to bridge internal divides\, share the industry pushing case studies and build market-leading customer experiences. \nAttend and gain unique insights on: \n\n          Collaborate or die.\nBreak internal silos in commercial and medical affairs\, partner with healthcare’s key innovators and decision makers\, and bring the brightest FMCG knowledge and leadership inside\n          You’re brand obsessed!\nCreate true customer partnerships and influence behaviours with an above-brand\, education-led approach\n          Digital transformation needs a cultural revolution.\nDemonstrate the value of digital initiatives to ensure adoption across affiliates and departments\n          Harness big data.\nPersonalise customer interactions with an internal infrastructure built to comprehend and connect insights\n          Achieve customer-centricity.\nEnsure new channel innovations and digital investments remain purpose-led to meet customer needs\n          Real-life technological innovation.\nChannel your investments and cut through unnecessary hyperbole with current applications of technology breakthroughs\n\n4 Reasons to Attend: \nCase Studies: Practical\, tangible advice and actions from your peers which you can put into practise in your own company \nOut of Industry Speakers: Hear from some of the biggest leader in marketing out of the pharma industry sharing their top tips \nTeam Benefits: Group rates are now available for 2+ attendees\, to ensure all interested peers can take advantage of this learning opportunity \nAll Stakeholders in One Room: Working together to ensure we are engaging in solution focused exchanges across all departments \nBook before 19th July to save €300
URL:https://www.pharmajournalist.com/event/marketing-and-customer-innovation-europe/
LOCATION:Novotel West London One Shortlands\, London\, W6 8DR\, United Kingdom
ORGANIZER;CN="eyeforpharma":MAILTO:mmayhew@eyeforpharma.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191016
DTEND;VALUE=DATE:20191018
DTSTAMP:20260515T032709
CREATED:20190625T090134Z
LAST-MODIFIED:20190625T090134Z
UID:21316-1571184000-1571356799@www.pharmajournalist.com
SUMMARY:LogiMed 2019
DESCRIPTION:LogiMed is the only European event designed for medical device supply chain directors and their teams. It is where Heads of Supply Chain and Logistics from the top pharma companies in Europe gather to benchmark\, interact\, network and develop professionally. \nOnly at LogiMed will you have the chance to learn from and network with all the major medical device companies\, key hospitals\, and the most innovative industry suppliers. All openly sharing the do’s and don’ts to help you adapt to new regulations\, redefine your supply chain strategy-covering planning\, logistics and customer service to achieve greater end-to-end supply chain operations. \nDownload the agenda to find out exactly who is speaking\, what the hottest topics are and how LogiMed can benefit you. LogiMed 2019 will bring together 250 Medical Device Supply Chain Professionals and 50 expert speakers over 2 value packed days. \nMixing interactive presentations from Global Heads of Supply Chain with practical\, interactive ‘how to’ case studies from proven procurement experts; LogiMed helps Medical Device Manufacturers to transform their supply chain. \nAs a proud Media partner of the event\, we are pleased to offer you an exclusive 15% discount off the full price to attend\, using our code: PHARMAJOUR19 \nBook your place online here: https://bit.ly/2J5viSu
URL:https://www.pharmajournalist.com/event/logimed-2019/
LOCATION:ROTTERDAM – NHOW HOTEL
ORGANIZER;CN="Worldwide Business Research":MAILTO:logimed@wbr.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191021
DTEND;VALUE=DATE:20191023
DTSTAMP:20260515T032709
CREATED:20190514T110507Z
LAST-MODIFIED:20190514T110507Z
UID:20716-1571616000-1571788799@www.pharmajournalist.com
SUMMARY:Highly Potent Active Pharmaceutical Ingredients USA (HPAPI) Conference
DESCRIPTION:SMi is delighted to announce its USA Highly Potent Active Pharmaceutical Ingredients conference coming to Boston on the 21th – 22th October 2019. \nThe inaugural HPAPI USA conference will explore how current technologies are streamlining the HPAPI industry with artificial intelligence and machine learning\, to improve risk assessment and validation. The latest emerging therapies will be discussed including bispecific antibodies\, oncolytic viral complexes and hormones. Will the super-high level 5 banding for these biologics prove effective or inept? Are current containment planning and solutions truly ensuing the health of workers? These questions will be answered along with unique insights including HPAPI manufacturing technologies. \nAttend the conference and join our networking platform with industry professionals to provide you with the expertise to overcome challenges. \nDISCUSSION HIGHLIGHTS: \nOncology Antibody-Drug Conjugates (ADC)\, the ongoing developments and the containment challenges imposed \nHow to correctly assess\, plan and implement the most cost-effective containment \nEmerging HPAPI therapies\, oncolytic viruses their potential and challenges \nAlternative HPAPI manufacturing technologies to reduce powder exposure and improving safety along with enabling continuous manufacturing \nThe reality of oncology ADC and HPAPI: are most drugs using ‘highly-potent’ to improve brand image? Has 50 years of ADC R&D for oncology with no cure shows signs of no promise? \nView the full agenda: www.hpapi-usa.com/PJwl
URL:https://www.pharmajournalist.com/event/highly-potent-active-pharmaceutical-ingredients-usa-hpapi-conference/
LOCATION:Sheraton Boston Hotel\, Boston USA\, United States
ORGANIZER;CN="SMi Group Limited":MAILTO:nhoward@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191022
DTEND;VALUE=DATE:20191025
DTSTAMP:20260515T032709
CREATED:20190806T094720Z
LAST-MODIFIED:20190806T094807Z
UID:21857-1571702400-1571961599@www.pharmajournalist.com
SUMMARY:Lab Asset & Facility Management In Pharma 2019
DESCRIPTION:The 2nd annual Lab Asset & Facility Management in Pharma summit is the only industry-led platform to join 120+ senior experts from Lab Operations\, Facility Management\, Lab Supplies and Procurement across pharma\, biotech\, CROs and research institutions. \n \nJoin your colleagues who are beginning to implement end-to-end asset management programs to optimize spend and gain better visibility of inventory and equipment lifecycles in order to maximize capital efficiency. \nAt the event\, you’ll delve into your core challenges\, including: \n\nHow to increase R&D productivity and avoid unnecessary downtime\nRevise the operating model for lab facility and asset supplies\nOptimize utilization of lab equipment and facility footprint\nExplore new technologies and IoT for asset monitoring and predictive maintenance\nExtend and manage your equipment lifecycle\nEvaluate your relationships and collaborations with OEMs\n\nDon’t miss out on this one of a kind meeting to engage with your peers and re-define best practice for tomorrow’s operations! \nTo learn more and to register online\, visit: https://ter.li/lafm-listing-home
URL:https://www.pharmajournalist.com/event/lab-asset-facility-management-in-pharma-2019/
LOCATION:The Westin San Diego\, 400 West Broadway\, San Diego\, CA\, 92101\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191022
DTEND;VALUE=DATE:20191025
DTSTAMP:20260515T032709
CREATED:20190924T120933Z
LAST-MODIFIED:20190924T120933Z
UID:22557-1571702400-1571961599@www.pharmajournalist.com
SUMMARY:2nd Targeted Protein Degradation Summit
DESCRIPTION:Finally Drug the “Undruggable” Through Targeted Protein Degradation.  Encapsulating the excitement of the field of protein degradation; The 2nd TPD Summit 2019 is the definitive\, comprehensive and industry-dedicated conference for the field of protein degradation – focused on optimizing target validation\, improving medicinal chemistry & rational design and ultimately accelerating the translation of selective\, bioavailable and effective protein degraders into clinical trials. \nWith 50+ speakers\, 40+ late-breaking case studies\, 3 dedicated streams\, 6 technical deep-dives & 400+ attendees\, TPD 2019 is the most comprehensive and the definitive guide for large pharma\, innovative biotech and leading academic researchers to capitalize on this emerging therapeutic class and make targeted protein degradation a blockbuster therapeutic approach that improves patient outcomes. \nAs the previously untapped drug discovery opportunity promised within the proteome becomes a reality and “undruggable” targets are finally being reached\, the field of targeted protein degradation is truly changing the face of small molecule drug discovery. In the pursuit to demonstrate safe and effective clinical results\, it’s clear that a set of unique development challenges must be overcome for these novel therapeutics to achieve their seemingly limitless potential. \nView the program and speaker list here: https://ter.li/idctdn
URL:https://www.pharmajournalist.com/event/2nd-targeted-protein-degradation-summit/
LOCATION:Hilton Boston Logan Airport\, One Hotel Drive\, Boston\, MA\, 02128\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191023
DTEND;VALUE=DATE:20191025
DTSTAMP:20260515T032709
CREATED:20170510T082131Z
LAST-MODIFIED:20190514T085314Z
UID:1755-1571788800-1571961599@www.pharmajournalist.com
SUMMARY:SAPHEX 2019
DESCRIPTION:SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre\, Johannesburg\, South Africa. \n \nSAPHEX serves a primary platform for both local and international companies working in the South African or Africa pharmaceutical manufacturing industry. The exhibition brings together key visiting pharma suppliers and buyers\, with a range of exhibitors from across the pharmaceutical sector. \nDon’t miss out on your chance to participate at this event. \nTo learn more about this event and to register online\, visit www.saphex.co.za \n 
URL:https://www.pharmajournalist.com/event/saphex/
LOCATION:GALLAGHER CONVENTION CENTRE\, 10 RICHARDS DRIVE\, HALFWAY HOUSE\, MIDRAND\, 1685\, South Africa
ORGANIZER;CN="SAPHEX":MAILTO:jessica@saphex.co.za
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191023
DTEND;VALUE=DATE:20191025
DTSTAMP:20260515T032709
CREATED:20180620T145021Z
LAST-MODIFIED:20190521T094434Z
UID:16375-1571788800-1571961599@www.pharmajournalist.com
SUMMARY:Lyophilization USA
DESCRIPTION:SMi Presents the 5th annual\nLyophilization USA Conference\nDate: October 23-24\, 2019\nWorkshop: October 25\, 2019\nLocation: Sheraton Boston Hotel\, 39 Dalton Street\, Boston\, MA\, USA\nWebsite: www.lyophilisation-usa.com/PJBan \nAbout Lyophilization USA \nThe SMi Group is pleased to invite you to the 5th Annual Lyophilization USA Conference arranged to take place on the 23rd and 24th October 2019\, in Boston. \n \nThe current list of FDA-approved biopharmaceuticals contains up to 50% of injectables and approximately a third of all parenterals being lyophilized\, which suggests it is the optimal way of ensuring stability in products that are unstable in aqueous solution. This instability or degradation can result in suboptimal product performance and even toxicity in worst cases indicating the need for lyophilization despite it’s inherently expensive running costs and time-consuming process. \nJoin us this year to explore novel and developing technologies that tackle the most pressing challenges and push innovation in world of lyophilization. Benchmark and network with industry leaders and discuss the most up to date and relevant topics that delve into alternative lyophilization approaches\, applied statistical modelling\, fresh views on scaling up and tech transfer\, pre- and post-product characterization. regulation and beyond. \nDISCUSSION HIGHLIGHTS: \nGain valuable insight into the most current challenges and considerations when working with highly concentrated and sensitive formulations \nExplore new and innovative approaches in model-based studies that utilise the power of statistical analysis to improve process development and understanding \nDiscuss the future outlook of lyophilization through trends in alternative approaches \nDiscover updates on the leading PAT technologies such as controlled nucleation\, continuous freeze drying\, low-frequency Raman\, vacuum-foam drying and more. \nListen to key opinion leaders and experts from regulatory bodies speak about expectations and the assessment of reliable technologies in the market \nView the full agenda: www.lyophilisation-usa.com/PJBan \nContact Info:\nT: +44 (0) 20 7827 6164\nE: nhoward@smi-online.co.uk
URL:https://www.pharmajournalist.com/event/lyophilization-usa-2019/
LOCATION:Sheraton Boston Hotel\, 39 Dalton Street\, Boston\, MA\, 02199\, United States
ORGANIZER;CN="SMi Group Ltd":MAILTO:nhoward@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191023
DTEND;VALUE=DATE:20191026
DTSTAMP:20260515T032709
CREATED:20180725T131813Z
LAST-MODIFIED:20190717T090554Z
UID:16872-1571788800-1572047999@www.pharmajournalist.com
SUMMARY:3rd Annual NASH Summit Europe 2019
DESCRIPTION:Welcome to Europe’s Gathering of NASH Drug Developers: The 3rd NASH Summit Europe\n\nDeepen Understanding of the Role of Liver Fibrosis in NASH\nConfidently Meet Regulatory Guidelines\nDefine Clinical Trial Endpoints\n\n \nReturning as the only NASH forum exclusively facilitating industry-to-industry dialogue and collaboration in Europe; the 3rd NASH Summit Europe will once again showcase leading data and leverage expert insights to advance pipeline success in NASH. \n“The NASH Summit was unlike any scientific meeting I have ever been to.  Everyone who attended was interested in some aspect of drug development for NASH.  I truly enjoyed the “applied science” focus of the meeting as it helped me where I most needed the help.  The opportunity to network and learn informally in the poster session and during receptions was excellent.”\nEli Lilly \nSee & hear from the 3rd NASH Summit Boston attendees to better understand how the NASH Summit is uniquely dedicated to advancing the therapeutic potential of NASH therapeutic \nTo learn more about this event\, and to register online\, visit https://nash-europe.com/ \nContact:\nPhone – +44 (0)20 3141 8700\nEmail – info@hansonwade.com
URL:https://www.pharmajournalist.com/event/nash-summit-europe/
LOCATION:The Waldorf Hilton\, London\, Aldwych\, London\, WC2B 4DD\, United Kingdom
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191023
DTEND;VALUE=DATE:20191026
DTSTAMP:20260515T032709
CREATED:20190712T103804Z
LAST-MODIFIED:20190712T104710Z
UID:21568-1571788800-1572047999@www.pharmajournalist.com
SUMMARY:Neuromuscular Drug Development Summit (NMD)
DESCRIPTION:Now in its 2nd year\, the industry-focused NMD Summit will overcome the challenges preventing neuromuscular drug developers bringing truly transformative therapeutics to market. \nWith an emphasis on ALS\, SMA\, DMD and other rare diseases\, 18 expert speakers from the likes of Biogen\, Audentes and PTC Therapeutics will share their insights across 3 packed days. \nJoin 90+ neuromuscular stakeholders at this definitive forum to exchange novel ideas\, gather lessons learned and establish new collaborations. \nTo learn more about this event\, and to register online\, visit https://ter.li/bgvvh7
URL:https://www.pharmajournalist.com/event/neuromuscular-drug-development-summit-nmd/
LOCATION:The Westin Boston Waterfront\, 425 Summer Street\, Boston\, Massachusetts\, 02210\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191023
DTEND;VALUE=DATE:20191026
DTSTAMP:20260515T032709
CREATED:20190827T091030Z
LAST-MODIFIED:20190827T091030Z
UID:22138-1571788800-1572047999@www.pharmajournalist.com
SUMMARY:BioNetwork 2019
DESCRIPTION:BioNetwork\nOctober 23 – 25\, 2019\nThe Ritz-Carlton Laguna Niguel\, CA \nFor the past 15 years\, BioNetwork has brought together the most senior-level decision makers in pharma and biotech deal-making (CEOs of BioTechs\, VPs of BD from Big Pharma). Meet the right people and create the ideal partnerships. \n \nDiscount Code: BN19PJ \nTo learn more about BioNetwork 2019 and to register online\, visit http://bit.ly/2ZnZSRN
URL:https://www.pharmajournalist.com/event/bionetwork-2019/
LOCATION:The Ritz-Carlton Laguna Niguel\, CA
ORGANIZER;CN="Worldwide Business Research":MAILTO:Cynthia.Liu@wbresearch.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191024
DTEND;VALUE=DATE:20191026
DTSTAMP:20260515T032709
CREATED:20190612T113524Z
LAST-MODIFIED:20190612T113524Z
UID:21136-1571875200-1572047999@www.pharmajournalist.com
SUMMARY:2nd Annual MarketsandMarkets Real-World Data and Life Science Analytics Congress
DESCRIPTION:MarketsandMarkets is proud to announce the 2nd Annual MarketsandMarkets Real-World Data and Life Science Analytics Congress to be held on 24th-25th October 2019 in Boston\, USA. With the increasing recognition of real-world data opportunities and challenges within the pharmaceutical and biotech industry\, life sciences organizations face clear decisions on how specifically to put resources into real-world evidence capacities. \nReal-World Evidence can possibly change the way life sciences associations use advancements to increase further clinical bits of knowledge and enable them and payers to collaborate like never before. After the successful inaugural\, the 2nd Annual Real-World Data and Life Science Analytics Congress will hold discussions on accelerating the adoption of Real-world evidence within the industry while understanding the capabilities of newer technologies for evidence generation. The congress will also address upcoming changes in the regulatory landscape with the recent framework by the FDA. \nOur aim for the 2nd Annual Real-World Data and Life Science Analytics Congress is to unite all stakeholders to see how to use conventional informational indexes and layer that in with innovative analytical techniques and new working models.
URL:https://www.pharmajournalist.com/event/2nd-annual-marketsandmarkets-real-world-data-and-life-science-analytics-congress/
LOCATION:Boston\, USA
ORGANIZER;CN="MarketsandMarkets Research Private Ltd.":MAILTO:Shardul.oza@marketsandmarkets.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191029
DTEND;VALUE=DATE:20191031
DTSTAMP:20260515T032709
CREATED:20190409T100329Z
LAST-MODIFIED:20190409T100329Z
UID:20268-1572307200-1572479999@www.pharmajournalist.com
SUMMARY:Skin Microbiome & Cosmeceutical Congress: USA
DESCRIPTION:This conference is dedicated to exploring the burgeoning field of skin microbiome research\, with case studies focusing on topics such atopic dermatitis\, psoriasis\, acne\, and allergy\, and the microbiome-based products being developed to fight these diseases. The conference will also provide insight into the future of microbiome-based cosmetics\, with numerous presentations on trial design\, commercial strategy\, and consumer awareness and expectations.
URL:https://www.pharmajournalist.com/event/skin-microbiome-cosmeceutical-congress-usa/
LOCATION:Paradise Point Resort & Spa\, San Diego\, USA\, United States
ORGANIZER;CN="Global Engage":MAILTO:info@globalengage.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191029
DTEND;VALUE=DATE:20191101
DTSTAMP:20260515T032709
CREATED:20190814T084713Z
LAST-MODIFIED:20190814T084713Z
UID:21959-1572307200-1572566399@www.pharmajournalist.com
SUMMARY:Inflammasome Therapeutics Summit
DESCRIPTION:The inaugural Inflammasome Therapeutics Summit (ITS) is the industry’s first dedicated discussion and networking forum focused on bringing together inflammasome thought-leaders to share their latest scientific progress and address the current challenges drug developers are facing. \n \nJoin 60+ of your peers and be part of this unique opportunity to engage in cross-industry discussions and presentations from over 19 expert speakers. \nWith a mission to bridge the gap between research and drug development and develop clinically effective candidates for inflammatory driven diseases\, ITS will hone in on the latest developments\, insights and science to elevate clinically effective inflammasome therapeutic pipelines. \nDeveloped in combination with experts from Nodthera\, Pfizer and IFM Therapeutics and other leading organisations. \nTo learn more about this event\, and to register online\, visit https://ter.li/su3nfj
URL:https://www.pharmajournalist.com/event/inflammasome-therapeutics-summit/
LOCATION:Revere Hotel Boston Common\, 200 Stuart Street\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191107
DTEND;VALUE=DATE:20191108
DTSTAMP:20260515T032709
CREATED:20190409T073558Z
LAST-MODIFIED:20190409T073558Z
UID:20262-1573084800-1573171199@www.pharmajournalist.com
SUMMARY:The Pharma Gorilla
DESCRIPTION:After a successful and overwhelming response of the Pharma Gorilla conference Mumbai on March 27\, The Conference Gorilla is organizing its 2nd and 3rd Edition of The Pharma on following dates and venues.  \n\nThe Pharma Gorilla | June 26\, 2019 | Le Meridien Singapore\, Sentosa\nThe Pharma Gorilla | Nov 07\, 2019 | New Delhi\, India\n\n The objective of this conference to share expertise addressing the current advancements involved in the Pharmaceutical industry. The knowledgeable intriguing sessions will create an ideal platform to get acquainted with the latest trends\, advancements\, and future of the pharmaceutical sciences. It is a wonderful opportunity for all the participants as it provides a networking opportunity to collaborate with the world class Pharmaceutical and healthcare industry. \nThe conference program have been designed in such way which can cover the trending topics under Keynote session\, exclusive presentation\, product lunch\, panel and round table discussion and it also provides a meaningful information. \nThe Pharma Gorilla provides a perfect platform for conducting presentations\, keynote sessions\, sharing the knowledge\, one on one meeting with your potential audience and getting acquainted with the latest developments in the pharmaceutical and healthcare industry to stand out of the competition. \nTarget Audience: 150+ Pharma professional from all over the Asia so I think it would be a good platform for you to accomplish your networking with the key decision makers of pharmaceutical companies\, software development companies\, CRO\, manufacturing\, formulation\, digital marketing and data management companies. \nGlimpse of Conference Agenda! \nConference Panels \n\nArtificial Intelligence in Pharma and Healthcare\nA disruptive take on marketing: Digital Marketing comes to Pharma\nScope of E-Pharmacy in Asia: Bringing New Dimensions to Pharma Industry\nLatest Trends in Formulation Development: A Global Perspective\nThe Impact of Regulatory Reform on Innovation in Drug Delivery Systems\n\nRoundtable Discussion \n\nImproving patient engagement and experience to improve clinical trials\n\nKeynote Session \n\nInnovation-driven and emerging technologies of Pharma Industry in Asia\nThe Global Pharma Industry: Policies\, Regulations and Key Trends 2019-2020\n\nExclusive Presentation \n\nRole of IPR in pharmaceutical industry\nCareer Growth Opportunities in the pharmaceutical industry\nImproving Biosimilars in manufacturing data\n\nFor any query\, contact us at contact@theconferencegorilla.com or IN: +91-813-004-7071 | US: +1-347-480-1588
URL:https://www.pharmajournalist.com/event/the-pharma-gorilla-3/
LOCATION:MA
ORGANIZER;CN="The Conference Gorilla":MAILTO:contact@theconferencegorilla.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191112
DTEND;VALUE=DATE:20191116
DTSTAMP:20260515T032709
CREATED:20190213T093434Z
LAST-MODIFIED:20190214T153532Z
UID:19515-1573516800-1573862399@www.pharmajournalist.com
SUMMARY:TIDES Europe: Oligonucleotide & Peptide Therapeutics
DESCRIPTION:TIDES Europe is Europe’s #1 forum for oligonucleotide and peptide leaders to build successful partnerships and accelerate new products to market. \n \n400+ OLIGONUCLEOTIDE AND PEPTIDE SCIENTISTS AND EXECUTIVES\nFast-track your oligonucleotide and peptide research to the clinic and beyond by collaborating with leading pharma\, biotechs\, academia and solution providers from North America\, Asia and Europe. \n40+ CASE STUDIES AND NEW DATA PRESENTATIONS\nHear best practices\, lessons learned and important industry developments across the entire spectrum of oligonucleotide and peptide development and production. \n30+ LEADING EXHIBITORS\nConnect with leading manufacturing\, technologies\, and service providers to drive your promising therapeutic towards commercial success. \nRegister now at www.TIDESEuropeEvent.com with code “PHARMJ10” and SAVE 10%.
URL:https://www.pharmajournalist.com/event/tides-europe-oligonucleotide-peptide-therapeutics/
LOCATION:RAI Amsterdam | Amsterdam\, Netherlands
ORGANIZER;CN="Knect365 Life Sciences":MAILTO:Allison.macdonald@knect365.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191112
DTEND;VALUE=DATE:20191115
DTSTAMP:20260515T032709
CREATED:20190812T093209Z
LAST-MODIFIED:20190812T093329Z
UID:21936-1573516800-1573775999@www.pharmajournalist.com
SUMMARY:Data Analytics for Pharma Development 2019
DESCRIPTION:Following a hugely successful event in Amsterdam last year\, we’re excited to inform you that the 5th Annual Data Analytics for Pharma Development Forum will be taking place in Munich from the 13-14 November 2019. Read all about it here:  Download the 2019 Agenda. \n \nThe industry needs to move past the challenge of unstructured data sets and integrating data from multiple sources to begin to work collaboratively with other departments and organisations\, as well as create a real world evidence framework for our pharmaceutical development through effective data utilisation. This is why we’ve curated an industry leading program with inside expertise from the top. \nSo – who exactly will be there? \nScientific Director\, Janssen\nPrinciple Data Scientist\, Novo Nordisk\nPrincipal Scientist Digitalisation Lead in Large Molecule Research\, Roche\nSenior Director\, Head\, Global Real World Evidence Strategy and Analytics\, Biogen\nHealth Informatics Director\, AstraZeneca\nVice President AI and Machine Learning\, BERG Health\nDirector\, Data Science IKU in EMEA\, Celgene\nGlobal HEOR Evidence Expert Lead\, Sanofi\nHead Quantitative Sciences\, Bill & Melinda Gates Medical Research Institute \nFor the first time ever we also bring you the Start-Up Afternoon\, where 5+ innovative data-management start ups demonstrate their technology in lightning-round presentations. \nWe also know that people learn better when they’re being active\, so this year we also running Certificate Course in Data Analytics to deep-dive into data strategy\, advanced analytics and machine learning & AI to ensure you’re at the forefront of innovation. \nWe encourage the sharing of challenges and success stories through an interactive program – but most importantly\, we facilitate open discussions during networking opportunities where our delegates from Big Pharma\, biotech\, and start-ups will be looking to you to inform their next step on how to optimise their data strategy. \nWith 50+ attendees and an expert speaker faculty of over 20 senior decision makers\, the Data Analytics forum is Europe’s industry leading event. \nDownload the 2019 Agenda here to find out more about the forum
URL:https://www.pharmajournalist.com/event/data-analytics-for-pharma-development-2019/
LOCATION:Hilton Munich City\, Rosenheimer Str. 15\, München\, 81667\, Germany
ORGANIZER;CN="IQPC":MAILTO:enquire@iqpc.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191112
DTEND;VALUE=DATE:20191114
DTSTAMP:20260515T032709
CREATED:20190916T083615Z
LAST-MODIFIED:20190916T083615Z
UID:22433-1573516800-1573689599@www.pharmajournalist.com
SUMMARY:Protein Engineering Congress EU
DESCRIPTION:Most enzymes found in nature are not suitable for industrial purposes. The field of protein and enzyme engineering is growing at a rapid rate\, with competition within industries high and the need to optimise performance greater than ever. \nIntroducing the European Protein Engineering Congress\, dedicated to uncovering the new and emerging practices\, techniques and methods of protein and enzyme engineering across industries. \nWith pharmaceutical\, flavour & fragrance\, consumer goods\, animal feed\, and agrochemical sectors all approaching the design\, build and generation of new biocatalysts and molecules not found in nature\, come and learn from our line-up of leading speakers to get an update on the new technologies used in the field of strain and protein engineering.
URL:https://www.pharmajournalist.com/event/protein-engineering-congress-eu/
LOCATION:Radisson Blu Hotel Frankfurt\, Franklinstrasse 65\, 60486\, Frankfurt am Main\, Germany
ORGANIZER;CN="Kisaco Research":MAILTO:events@kisacoresearch.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191113
DTEND;VALUE=DATE:20191115
DTSTAMP:20260515T032709
CREATED:20190731T104534Z
LAST-MODIFIED:20190731T113531Z
UID:21753-1573603200-1573775999@www.pharmajournalist.com
SUMMARY:5th annual European Microbiome Congress
DESCRIPTION:The gut microbiota’s importance in human health and disease progression spreads far wider than just gastro-intestinal conditions. The immune\, nervous and metabolic systems couple the microbiome with the rest of the body and thus play a crucial and interlinking role in extra-intestinal diseases including neurological\, cancer and metabolic conditions. \n \nFor the 5th annual European Microbiome Congress\, we’ve shifted the focus from gastro-intestinal to extra-intestinal as we examine the latest pre-clinical and clinical data demonstrating the gut microbiota’s role in some of the world’s most critical and costly diseases in modern society. \nJoin key opinion leaders from across academia and industry to examine the latest research data. This is your opportunity to find out how others plan to translate the latest understanding of the gut-microbiome into therapeutic drugs that have the power to treat cancer\, metabolic\, neurodegenerative and psychiatric disorders. \nTo learn more about 5th annual European Microbiome Congress\, and to register online\, visit https://microbiomecongress.com
URL:https://www.pharmajournalist.com/event/5th-annual-european-microbiome-congress/
LOCATION:Olympia Conference Centre\, Hammersmith Rd\, Hammersmith\, London W14 8UX
ORGANIZER;CN="Kisaco Research":MAILTO:events@kisacoresearch.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191113
DTEND;VALUE=DATE:20191115
DTSTAMP:20260515T032709
CREATED:20190829T084945Z
LAST-MODIFIED:20190829T085516Z
UID:22152-1573603200-1573775999@www.pharmajournalist.com
SUMMARY:Skin Microbiome Congress EU
DESCRIPTION:With 2.35 billion Euros being spent on cosmetic product R&D in Europe\, and Skin Microbiome being “2019’s hottest skin care trend” – a claim supported by major market researchers and beauty bibles\, are you ready for the next generation of skin care? \nWe are bringing you the first data focused Skin Microbiome event with two concurrent tracks focused on the hard data and commercial sides of skin microbiome: \n\nData Track: focuses on the hard data that supports and legitimises product claims and drives increased understanding of the skin microbiome.\nCommercial Track: tackles the challenges faced when building a commercially viable skin microbiome company\, optimising your supply chain and executing successful marketing & communication strategies.\n\nDiscover the potential of prebiotic\, probiotic and postbiotic products being developed to protect and promote a healthy microbiome and ultimately combat dermatological conditions from acne and eczema to dandruff and skin allergies. Take advantage of: \n\nEffective Networking with 150+ innovators\, start-ups\, multinational companies and vendors.\nCutting Edge Research – Discover the latest advancement in therapeutic & cosmetic products containing live bacteria\, bacterial extracts\, or active ingredients to promote & protect the skins microbiome.\nConsumer Trends – Understand how consumer trends towards natural\, organic products and active beauty are shaping the evolution of products adapted to the skin microbiome.\nClinical Trials – Explore how to design an effective clinical trial & translate research into clinically & commercially viable therapeutics.\nCompetitive Edge – Determine how to differentiate your product line & seize this market opportunity\, gaining market share with scientifically backed products.\nRegulation – Understand the different paths to market & regulatory considerations necessary to launch a cosmetic or therapeutic product.\n\nWith an increasing consumer trend towards natural products\, what’s more natural than harnessing the bacteria on your skin? Don’t miss your chance to understand the next generation of natural skincare products!
URL:https://www.pharmajournalist.com/event/skin-microbiome-congress-eu/
LOCATION:Olympia London\, Hammersmith Road\, Kensington\, London\, W14 8UX
ORGANIZER;CN="Kisaco Research":MAILTO:events@kisacoresearch.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191118
DTEND;VALUE=DATE:20191121
DTSTAMP:20260515T032709
CREATED:20180531T073809Z
LAST-MODIFIED:20190605T115541Z
UID:16039-1574035200-1574294399@www.pharmajournalist.com
SUMMARY:Ophthalmic Drugs
DESCRIPTION:SMi Group are pleased to present the 3rd Annual Ophthalmic Drugs Conference and Focus Day\, taking place on the 18th-20th November 2019 in London\, UK. \n \nThe global ophthalmic drug market size is expected to reach a value of $30 billion USD by 2023 with growing focus on alternative delivery approaches to replace intravitreal drug delivery and novel drug development being the key factors driving the market. \nWith this in mind\, this year’s Ophthalmic Drugs conference will explore new discoveries in the treatment of ocular rare disease; innovations in gene therapy; the challenges in drug delivery through a complex barrier; patient comfort and regulatory compliance which make up  core components within the Ophthalmic Drug sphere. \nNEW FOR 2019: \nThe brand-new Focus Day on ‘Novel Drug Delivery Through a Complex Barrier’ will bring academic perspectives on the future for ocular drug delivery and notified bodies will provide a regulatory insight into this emerging field of ophthalmic drug development. \nHow will you benefit? \nWith over 15 expert presentations\, the three-day agenda offers you peer-to-peer networking with Global Product Managers\, Heads of Drug Development\, Senior Directors of Ophthalmology\, Heads of Research and Development and many more! \nNetwork and learn from leading professionals such as: \nCHAIRS FOR 2019: \n\nMitchell de Long\, Vice President\, Chemistry\, Aerie Pharmaceuticals\nNaj Sharif\, Vice President\, Global Ophthalmology\, Santen Inc\, USA\n\nFEATURED SPEAKERS INCLUDE: \n\nParisa Zamiri\, Global Head of Clinical Development in Ophthalmology\, Novartis Pharmaceutical Inc.\nGavin Spencer\, Executive Vice President and Chief Business Officer\, Nicox\nAniz Girach\, Chief Medical Officer\, ProQR Therapeutics\nDaniel Chung\, Global Medical Strategy Lead- Ophthalmology\, Spark Therapeutics\nMichael Ehrlich\, Senior Clinical Program Lead – Retinopathies\, Boehringer Ingelheim\nPeter Morgan-Warren\, Medical Assessor\, MHRA\nWilliam Dallman\, Clinical Development Manager\, Eyenuk\n\nFor more information and to register\, visit: www.ophthalmicdrugs.com/pj \nEarly-Bird Rates \n\nBOOK BY 28TH JUNE AND SAVE £300\nBOOK BY 30TH SEPTEMBER AND SAVE £100\n\nSocial Media Handles \nFollow us on LinkedIn ‘SMi Pharma’\, Twitter @SMiPharm and use #OphthalmicDrugs \nContact Info: \nT: +44 (0) 20 7827 6164\nE: nhoward@smi-online.co.uk
URL:https://www.pharmajournalist.com/event/ophthalmic-drugs-2019/
LOCATION:Copthorne Tara Hotel\, Scarsdale Place\, Kensington\, London\, W8 5SY\, United Kingdom
ORGANIZER;CN="SMi Group Ltd":MAILTO:nhoward@smi-online.co.uk
END:VEVENT
END:VCALENDAR